• 23 Jul 25

IXICO’s competitive edge: Focused expertise in brain disorders - P2

IXICO’s competitive edge: Focused expertise in brain disorders - P2

IXICO Plc | IXI | 12.2 0 0%

    • 37 views

 

Discover what sets IXICO PLC (LSE:IXI, OTC:PHYOF) apart from competitors. CEO Bram Goorden highlights the company’s exclusive focus on neurodegenerative diseases, its proven track record in biomarkers, and how decades of regulatory expertise make it a trusted partner.

Click the link in the video, or visit the IXICO profile to view the full interview.

#Neuroscience #CNS #Biomarkers #ClinicalResearch #LifeSciences #IXICO #Neuroimaging #AlzheimersResearch #ParkinsonsDisease #AIDrivenHealthcare #Biomarkers #ClinicalResearch #HealthcareInnovation #UKStocks #BramGoorden #ProactiveInvestors #MedicalAI #LifeSciences #PostMarketingSurveillance #AI #AIinHealthcare #Alzheimers #Parkinsons #BiotechInnovation

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via our Refer a Friend page. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

AI at the heart: IXICO’s technology roadmap for the future - P3

Companies: IXICO Plc

Proactive meets IXICO's new chief business officer Lammert Albers

Companies: IXICO Plc

IXICO raises revenue guidance on expanded pipeline

Companies: IXICO Plc

IXICO PLC - Proactive One2One Virtual Event

Companies: IXICO Plc

Inside IXICO: Driving innovation in neuroimaging and growth strategy - P1

Companies: IXICO Plc

IXICO PLC reports first year of profitability 'well ahead of expectations'

Companies: IXICO Plc

© Research Tree 2025

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top